Mankind Pharma Limited (NSE:MANKIND)

Mankind Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 22, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	886,292	1,000,400	921,654	-	-	-
Market Cap Growth	-26.87%	8.54%	-	-	-	-
Enterprise Value	937,420	960,198	902,241	-	-	-
Last Close Price	2147.00	2423.79	2299.84	-	-	-
PE Ratio	50.43	50.25	48.18	-	-	-
Forward PE	38.74	45.13	43.88	-	-	-
PS Ratio	6.54	8.20	8.98	-	-	-
PB Ratio	5.71	6.87	9.63	-	-	-
P/TBV Ratio	-	-	12.00	-	-	-
P/FCF Ratio	37.67	51.24	50.17	-	-	-
P/OCF Ratio	30.84	41.45	42.82	-	-	-
PEG Ratio	2.48	2.64	1.91	-	-	-
EV/Sales Ratio	6.92	7.87	8.79	-	-	-
EV/EBITDA Ratio	28.83	32.12	35.87	-	-	-
EV/EBIT Ratio	38.57	39.89	41.96	-	-	-
EV/FCF Ratio	39.84	49.18	49.11	-	-	-
Debt / Equity Ratio	0.54	0.58	0.02	0.02	0.14	0.06
Debt / EBITDA Ratio	2.58	2.84	0.08	0.09	0.44	0.16
Debt / FCF Ratio	3.56	4.36	0.11	0.17	1.94	0.34
Asset Turnover	0.63	0.62	0.95	0.93	1.00	1.09
Inventory Turnover	2.24	2.01	2.17	1.84	1.69	1.77
Quick Ratio	0.76	0.73	2.05	1.14	0.65	1.78
Current Ratio	1.14	1.23	3.10	2.32	1.68	2.89
Return on Equity (ROE)	13.46%	16.62%	22.57%	18.79%	25.99%	30.30%
Return on Assets (ROA)	7.07%	7.58%	12.40%	10.53%	14.76%	17.37%
Return on Invested Capital (ROIC)	9.65%	14.28%	27.63%	20.42%	29.77%	41.50%
Return on Capital Employed (ROCE)	11.10%	10.90%	21.80%	20.20%	28.10%	31.70%
Earnings Yield	1.98%	1.99%	2.08%	-	-	-
FCF Yield	2.65%	1.95%	1.99%	-	-	-
Payout Ratio	2.36%	-	-	-	-	-
Buyback Yield / Dilution	-2.35%	-0.88%	-0.14%	-0.00%	-	-
Total Shareholder Return	-2.25%	-0.88%	-0.14%	-0.00%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.